Leah Morgan · CFO · ClearPath Holdings
Proposed Sale $8.5M notice · filed 4 days ago
See executive stock sales, proposed sales and the details that give you a timely reason to call.
Get there while the opportunity is fresh · Stop chasing stale lists · Call with a reason, not a guess
Proposed Sale $8.5M notice · filed 4 days ago
Stock Sale $4.2M observed sale · recent activity
Option Exercise $2.1M estimated spread · no connected sale yet
Cold lists tell you who might be wealthy. A timely equity event gives you a reason to act while the conversation is still relevant.
Long lists. Generic outreach. No reason the executive should care today.
See the event, the size and the context—then decide whether it deserves a call before the opportunity goes cold.
Affluensee should improve your prospecting odds—not give you another database to babysit.
Start with executives whose public equity activity just changed, so your prospecting begins with a real event.
See the dollar amount, timing and recent activity so you can prioritize the few names worth researching.
Show up knowing what happened and why it may matter, instead of opening with a generic pitch.
You should be able to open Affluensee and answer one question fast: who is worth my time today?
ClearPath Holdings
A material proposed sale can make diversification, tax planning, charitable giving and broader wealth planning more relevant right now.
At $5,000 a year, the standard isn’t “is this cheap software?” It’s whether Affluensee helps you find one relationship you otherwise would have missed.
Illustration only. Advisory fees, client assets and conversion outcomes vary. Affluensee does not guarantee client acquisition.
Affluensee gives you the public context. Your firm keeps control of research, outreach and compliance. Review the methodology →
A prioritized view of public-company executives with recent equity activity, including event type, timing, available dollar context, connected history and source evidence.
Affluensee focuses on proposed sales, completed insider transactions, option activity and related executive-equity signals, including relevant 10b5-1 context where available.
Yes. The product is designed around target companies and markets so advisors can narrow attention to the executives that fit their practice.
No. Research and outreach stay with your firm. Affluensee helps you decide who deserves attention and gives you the public context to prepare.
$500 per month or $5,000 annually for advisor access.
See the executives whose financial picture just changed and decide who is worth your next call.